Athenex's Unattributed VC Round

Athenex raised a round of funding on September 20, 2005. Investors include Niagara Region Venture Fund.

Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases an…

Articles about Athenex's Unattributed VC Round: